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Summary 
Using a fluorescein-conjugated antigenic peptide, 
peptide-receptive H-2K b MHC class I molecules were 
found throughout the secretory pathways of RMA cells 
and peptide transporter (TAP)-deficient derivative 
cells (RMA/S). RMA/S cells displayed higher levels of 
intracellular peptide-receptive molecules, while, sur- 
prisingly, RMA cells expressed 3- to 5-fold more cell 
surface peptide-receptive molecules. Metabolic radio- 
labeling of Kb-associated oligosaccharides with [1-3H]ga- 
lactose demonstrated that despite a large difference 
in the fraction of K b molecules in native conformation 
in detergent extracts, K b transport rates from the trans- 
Golgi complex to the surfaces of RMA and RMA/S cells 
were similar. Thus, although considerable numbers of 
class I ~ chains reach the RMA/S cell surface, they are a 
less productive source of peptide-receptive molecules 
than class I molecules synthesized by TAP-expressing 
RMA cells, suggesting paradoxically that TAP func- 
tions to increase the amount of peptide-receptive mol- 
ecules at the cell surface. 
introduction 
Class I molecules of the major histocompatibility complex 
(MHC) are heterotrimers consisting of a polymorphic 43 
kDa integral membrane glycoprotein (~ chain), an invari- 
ant 12 kDa protein (l~2-microglobulin [132m]), and a peptide 
usually composed of 8-10 residues. The only known func- 
tion of class I molecules is to present such oligopeptides 
to CD8 expressing T lymphocytes (Tco~+) (Koller et al., 
1990; Zijlstra et al., 1989). In most cases, peptides are 
derived from cytosolic or nuclear proteins (Townsend and 
Bodmer, 1989; Yewdell and Bennink, 1992), possibly 
through the action of proteasomes, macromolecular multi- 
catalytic proteases abundant in the cytosol and nucleus 
(Monaco, 1992). Such peptides are delivered to the secre- 
tory pathway via the transporter associated with antigen 
processing (TAP) (Townsend and Trowsdale, 1993), which 
is formed by the association of MHC-encoded TAP1 and 
TAP2 gene products. Peptides bind to preformed ~132m 
heterodimers, which associate loosely in the absence of 
a peptide ligand. Prior to their association with peptides, 
the heterodimers are tethered to TAP (Ortmann et al., 
1994; Suh et al., 1994), presumably to facilitate assembly 
by increasing the effective concentration of TAP-trans- 
ported peptides. Potentially, TAP could also act as a mo- 
lecular chaperone in facilitating class I folding or assembly. 
In mouse cells, ~l~2m heterodimers have been reported to 
bind to calnexin, a resident endoplasmic reticulum (ER) 
molecular chaperone that binds a large number of nascent 
membrane proteins in addition to class I molecules (David 
et al., 1993; Ou et al., 1993; Degen and Williams, 1991). 
The kinetics of class I binding and release to TAP and 
calnexin appear to be identical (Suh et al., 1994). These 
findings can be reconciled if al~2m heterodimers bind to 
TAP in a complex with calnexin in mouse cells. 
The creation of a stable ternary complex is critical to 
the surface expression of native class I molecules, since 
relative to normal cells, TAP-deficient cells express sub- 
stantially lower levels of surface class I molecules reactive 
with MAbs specific for native class I molecules (Townsend 
et al., 1989; Ljunggren et al., 1989). Class I molecules 
capable of binding exogenously added peptides are pres- 
ent on the surface of both normal and TAP-deficient cells, 
and also exist in detergent extracts of metabolically radio- 
labeled cells (Townsend et al., 1989). Peptide binding in- 
duces conformational alterations in class I molecules most 
easily measured by an increase in resistance to thermal 
denaturation as determined by the loss of binding to mono- 
clonal antibodies (MAbs) specific for the native conforma- 
tion. Class I molecules that bind peptides are convention- 
ally referred to as"empty" class I molecules. It is essentially 
unknowable, however, to what extent hese molecules are 
truly empty, i.e., contain solvent in their binding groove 
versus a weakly bound protein ligand. In the present pa- 
per, we refer to peptide-binding class I molecules as pep- 
tide receptive, which emphasizes the operational nature 
of the definition. Additionally, in this operational spirit, we 
distinguish between TAP-dependent and TAP-indepen- 
dent pools of class I molecules to refer, respectively, to 
those molecules whose folding was or was not influenced 
by the functioning of TAP. 
In the present study, we use a fluorescein-conjugated 
H-2Kb-binding synthetic peptide in conjunction with bio- 
chemical analysis of [1-3H]galactose-labeled K b and H-2D b 
to explore the source and intracellular trafficking of pep- 
tide-receptive class I molecules. Our findings demonstrate 
that a substantial number of peptide-receptive molecules 
are released from the ER of both TAP-expressing and 
TAP-deficient cells, providing a ready explanation for the 
puzzling observation that TAP-deficient cells exhibit nor- 
mal levels of class I molecules throughout he stacks of 
Golgi complex by immunoelectron microscopy (Baas et 
al., 1992). We also show that despite the considerable flux 
of class I molecules to the cell surface of TAP-deficient 
cells through the trans-Golgi complex, such cells actually 
possess less peptide-receptive Kb molecules than TAP- 
expressing cells, thus paradoxically demonstrating a role 
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Figure 1. Binding of OVA-FL to Live Cells 
A. The amount of OVA-FL bound to cells incubated at 0°C for 10 min 
with OVA-FL at the indicated concentration was determined by flow 
cytometry. The mean channel fluorescence (MCF) of viable cells is 
shown on the y axis. 
B. Peptide competition ofOVA-FL-binding live cells. The amount of 
OVA-FL bound to cells incubated with 5 i.tg/ml OVA-FL in the presence 
of increasing amounts of unlabeled peptides (solid lines) was deter- 
mined by flow cytometry. Alternatively, cells were incubated with com- 
petitor peptides at 0°C for 10 min, washed, and then incubated with 
OVA-FL (dotted lines). 
Results 
Binding of OVA-FL to Live Cells 
To characterize the intracellular trafficking of peptide- 
receptive K b molecules, we used a Kb-binding peptide from 
ovalbumin (residues 257-264, SIINFEKL). To monitor the 
interaction of peptide with cells, the ~ amino group of the 
lysine residue at position 7 was conjugated to fluorescein 
(termed OVA-FL). This strategy was adopted because it 
has been demonstrated that substitution of this lysine with 
other amino acids affects T cell recognition, but not pep- 
tide binding to K b (Jameson and Bevan, 1992; Jameson 
et al., 1993). This is consistent with X-ray crystallographic 
findings that the side chain of residue 7 is directed away 
from the K b peptide-binding roove towards the solvent 
(Zhang et al., 1992; Fremont et al., 1992). 
The binding of OVA-FL to class I molecules on live cells 
was first characterized by flow cytometry. To avoid active 
peptide internalization, cells were incubated in all experi- 
ments with OVA-FL on ice. Figure 1A shows the binding 
of increasing amounts of OVA-FL to RMA cells, a T cell 
lymphoma that expresses K b and D b molecules, and con- 
trol P815 cells that express H-2K ~, D d, and L ~ molecules. 
Additionally, nonpolymorphic MHC class Ib molecules 
(and non-MHC molecules) that could potentially bind pep- 
tides are expressed by both cells. Selective binding of 
OVA-FL to RMA cells was clearly evident under these con- 
ditions. The binding of increasing concentrations of OVA- 
FL to RMA cells was biphasic, with an initial inflection 
occurring at approximately 20 nM, and a plateau occurring 
at concentrations between 1 and 5 p.M. At concentrations 
of OVA-FL above 5 ~M, binding to P815 cells increased. 
As this binding was not K b specific, 5 ~tg/ml (3.7 I~M) was 
chosen as the standard concentration in experiments de- 
scribed below. The specific binding of OVA-FL to K b was 
confirmed in an additional experiment, in which L929 cells 
(H-2 k) expressing K b from a transfected gene, bound OVA- 
FL at levels similar to those observed with RMA cells, while 
binding of OVA-FL to nontransfected L929 cells occurred 
at levels close to cellular autofluorescence values (data 
not shown). 
We next examined the ability of unlabeled peptides to 
compete with the binding of OVA-FL to RMA cells (Figure 
1B, solid lines) by incubating cells on ice with various con- 
centrations of unlabeled peptides diluted into 5 ~tg/ml 
OVA-FL. OVA-FL binding was markedly inhibited by K b- 
binding peptides FAPGNYPAL and SIINFEKL (unconju- 
gated ovalbumin peptide), while the Kd-binding peptide 
TYQRTRALV inhibited binding only slightly, and then only 
at the highest concentration tested. SIINFEKL achieved 
a calculated 50% inhibition of OVA-FL binding when pres- 
ent at an equimolar concentration. This indicates that con- 
jugation of fluorescein to the peptide did not alter the 
affinity of the peptide for K b. FAPGNYPAL was an approxi- 
mately 10-fold more effective competitor of OVA-FL than 
SIINFEKL. 
As an alternative method, competition assays were per- 
formed by first incubating cells with unlabeled peptides 
for 20 min on ice, washing, and then incubating with 5 i.tg/ 
ml OVA-FL (Figure 1B, dotted lines). Under these condi- 
tions enhanced competition was observed, with nearly 
complete competition by FAPGNYPAL. In additional ex- 
periments performed similarly, either of two Db-binding 
peptides tested, ASNENMETM or QGINNLDNL, reduced 
OVA-FL binding by 30%, as opposed to 10% or lower 
inhibition by three different Kd-binding peptides (data not 
shown). This finding is consistent with observations that 
nonmodified SIINFEKL binds D b, as determined by in- 
creased expression of D b molecules on RMA/S cells follow- 
ing overnight incubation with high peptide concentrations 
at 37°C (data not shown). 
The inability of OVA-FL to bind to cells pulsed with FAP- 
GNYPAL indicated that OVA-FL could not displace high 
affinity peptides from K b. This conclusion was confirmed 
by incubating RMA cells OVA-FL on ice, washing, and 
incubating on ice with unlabeled SIINFEKL at 5 or 50 I~g/ 
ml. This resulted in the loss of negligible amounts of bound 
peptide (3°/o and 4%, respectively), indicating that little, 
if any, exchange of high affinity peptides occurs under the 
assay conditions employed. 
Role of p2m in the Creation of Peptide-Receptive 
K b Molecules 
The presence of exogenous ~2m has been found to en- 
hance greatly the binding of peptides to class I molecules, 
as assessed either by incubation of cells with peptides at 
37°C (Rock et al., 1990, 1991 b; Vitiello et al., 1990; Otten 
et al., 1992), or in detergent extracts in the cold (Townsend 
et al., 1990). The addition of either bovine ~2m (in the form 
of 2% fetal bovine serum [FBS]) (Figure 2B), or human 
132m at concentrations up to 5 i.tg/ml (data not shown) had 
no effect on the binding of OVA-FL to cells at 0°C. In 
this experiment, he effect of increasing the expression of 
peptide-receptive class I molecules at the cell surface by 
incubating cells overnight at 26°C was examined (Ljung- 
gren et al., 1990). Cells incubated at 26°C bound approxi- 
mately twice as much OVA-FL as cells incubated at 37°C. 
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Figure 2. CharacterizationofOVA-FkBindingtoSurfaceand Intracel- 
lular K b Molecules 
A. Affect of IFN~/on cell surface and intracellular expression of peptide- 
receptive and MAb-reactive K b molecules. RMA and RMA/S cells were 
cultured for 48 hr at 37°C in the absence or presence of 20 U/ml 
IFNy. The cell surface expression of K b molecules was determined by 
incubating cells for 20 min at 0°C with anti-Kb-FL. OVA-FL binding to 
cells was by incubating cells for 10 min at 0°C in the presence of 
10 gg/ml of ASNENMETM to block OVA-FL binding to D b. Binding to 
live cells was quantitated by flow cytometry. The intracellular binding 
of OVA-FL was performed using cells fixed with 1.0% paraformalde- 
hyde for 10 min at room temperature and washed three times in PBS 
containing 200 mM glycine. Anti-Kb-FL and OVA-FL were diluted in 
PBS-azide supplemented with 0.1% (w/v) saponin to enable access 
to intracellular ligands. After washing with PBS supplemented with 
saponin, binding was quantitated by flow cytometry. The levels of non- 
specific binding to P815 cells are subtracted from each value. 
B. Influence of exogenous 132m on OVA-FL binding at 0°C. RMA cells 
cultured at 37°C or 26°C for 18 hr prior to assay were incubated for 
30 min with OVA-FL in PBS-azide, or PBS-azide containing 2% FBS 
as a source of extracellular 1~2m. The amount of OVA-FL bound after 
30 min incubation at 0°C was determined by flow cytometry. 
C. Requirement for exogenous 132m in the formation of peptide- 
receptive K b molecules. Cells were cultured for 18 hr in RPMI 1640 
supplemented with either 7.5% (v/v) FBS or human 13zm (5 gg/ml), 
washed twice in ice-cold PBS, and tested by cytofluorography for bind- 
ing to OVA-FL or, via indirect immunofluorescence, to BBM.1, a MAb 
specific for human 1~2m. Data are expressed as percentage of maxi- 
mal binding to RMA cells and are corrected for background levels. 
Maximal binding of OVA-FL to RMA cells, 207; background binding, 
4. Maximal binding of BBM.1 to RMA cells, 462; background binding 
(no first antibody), 16: 
D. Decay of peptide-receptive K b molecules. Cells incubated for 18 hr at 
37°C with media supplemented with 5 i~g/ml human I~m were washed 
twice with PBS and incubated for up to 40 min in serum-free medium 
supplemented with 5 gg/ml BFA. Cells were then tested for OVA-FL 
binding on ice. Data are expressed as percentage of binding to cells 
incubated immediately on ice after washing. The 100o/o value for RMA 
cells, 255; 100% value for RMA/S cells, 81. 
Again, the binding of OVA-FL to these cells was not en- 
hanced by the addition of 2% FBS. 
While exposure of cells to 1~2m at 0°C had no discernible 
effect on OVA-FL binding, the formation of peptide- 
receptive K b molecules was dependent on culturing cells 
in 132m containing medium. Thus, if cells were cultured 
overnight in serum-free media, OVA-FL binding was re- 
duced nearly to background autofluorescence levels (Fig- 
ure 2C). Addition of human 132m to the same medium en- 
hanced OVA-FL binding 12-fold over levels observed after 
culturing in normal growth medium (RPMI 1640 with 7.5% 
FBS [v/v]). Supplementing normal medium with 5 ~g/ml 
human 1~2m boosted OVA-FL binding 8-fold. The increase 
in OVA-FL binding parallels the binding of human 132m as 
detected by a human 1~2m-specific MAb directly conju- 
gated to fluorescein (Figure 2C). In competit ion studies 
performed in conjunction with those shown in Figure 1B, 
nearly identical results were obtained using RMA cells 
(and RMA/S cells, see below) cultured overnight in media 
containing human 132m to enhance the number of peptide- 
receptive K b molecules. Thus, the additional peptide- 
receptive K b molecules created by culturing cells in human 
132m are indistinguishable from those present in cells cul- 
tured in FBS containing medium. 
The stability of peptide-receptive human 1~2m containing 
K b molecules was determined by incubating human 132m- 
loaded cells at 37°C in 132m-free media (see Figure 2D). 
This revealed a biphasic decay in peptide receptivity, with 
an initial rapid decay resulting in a loss of 80% of peptide- 
receptive molecules after 20 min incubation. By contrast, 
peptide-receptive molecules are stable for many hours 
when incubated at 0°C in 132m-free media. 
Taken together, these findings indicate that the vast ma- 
jority of the peptide-receptive molecules on RMA cells are 
unstable molecules formed by the association of class I 
heavy chains with 1~2m present in the extracellular medium. 
Surface Expression of Peptide-Receptive K b 
Molecules on RMA and RMA/S Cells 
The involvement of TAP in the production of peptide- 
receptive K b molecules was examined using RMNS cells, 
which fail to express functional TAP, owing to their inability 
to synthesize TAP2, which combines with TAP1 to form 
TAP (Attaya et al., 1992; Yang et al., 1992). The absence 
of TAP-transported peptides leads to the inefficient export 
of class I molecules, and results in a very large decrease 
in steady-state levels of class I molecules present on the 
plasma membrane that are reactive with MAbs (Townsend 
et al., 1989). The expression of class I molecules on RMA 
and RMA/S cells was quantitated by incubating cells at 
O°C with the Kb-specific MAb AF6-88.5 conjugated to fluo- 
rescein (termed anti-KbFL). This MAb is specific for native 
K b molecules containing mouse 1~2m and is not reactive 
with K b associated with bovine or human ~2m (Rock et al., 
1991b) (we confirmed the lack of reactivity of KbFL with 
human 1~2m containing heterodimers). RMNS cells ex- 
press only 3%-4% of the mouse ~2m containing K b mole- 
cules expressed by RMA cells (a f luorescein-conjugated 
Db-specific MAb [KH95; Hasenkrug et al., 1987] binds at 
even lower relative levels to RMNS cells [data not shown]) 
(Figure 2A). These values are in close agreement with the 
finding that a radioiodinated MAb specific for mouse ~2m 
binds to RMA cells at 60-fold higher levels than RMNS 
cells (Rock et al., 1991a). They are 3- to 4-fold lower, how- 
ever, than values obtained by indirect immunofluores- 
cence in some studies, which we attribute to an underesti- 
mate in RMA staining, probably owing to limiting amounts 
of primary or secondary antibodies. 
Surprisingly, in a large number of experiments OVA-FL 
consistently bound at lower levels to RMA/S cells than to 
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RMA cells (see Figure 1A; Figures 2A-2C). As seen in 
Figure 1, the half-maximal binding of OVA-FL to RMA and 
RMA/S cells was achieved at nearly the identical concen- 
tration, indicating that the affinity of the peptide for the 
two cells was similar, but that more sites were available 
on RMA cells. Consistent with this conclusion, the inhibi- 
tion of binding of OVA-FL to RMA and RMA/S cells by 
unlabeled peptides under various conditions was virtually 
identical (see Figure 1B). As with RMA cells, binding of 
OVA-FL was dependent on the association of exogenous 
132m with surface class I molecules, could be enhanced 
by culturing cells in media containing human l~2m, and 
paralleled the binding of human 132m (Figure 2C). Peptide- 
receptive K b molecules containing human 1~2m on RMA 
and RMA/S cells were lost with identical kinetics when 
cells were incubated at 37°C in 132m-free media (Figure 
2D). These findings connote a high degree of similarity 
between peptide-receptive Kb molecules on RMA and 
RMA/S cells. 
The increased binding of OVA-FL to the surface of RMA 
cells relative to RMA/S cells contrasts with the binding of 
OVA-FL to intracellular class I molecules, where greater 
amounts of peptide bound to RMA/S cells than RMA cells 
(described below). Thus, the increased amount of peptide- 
receptive molecules on the surface of RMA cells cannot be 
attributed to enhanced levels of K b synthesis, but instead 
indicates that many of the peptide-receptive molecules 
detected by OVA-FL on RMA cells are derived from a TAP- 
dependent pool of molecules. 
To explore further the relationship between class I ex- 
pression and OVA-FL binding, cells were treated for 48 
hr with interferon y (IFNy), which increases transcription 
of numerous genes, including those encoding c~ chains, 
132m, and TAP. This resulted in a 2.7-fold increase in the 
already substantial amount of MAb-reactive K b on the sur- 
face of RMA cells (Figure 2A), By contrast, little additional 
K b molecules were detected on RMA/S cells. This is not 
owing to the failure of RMA/S cells to respond to IFNy, 
since the amount of K b detected intracellularly rose sub- 
stantially in RMA/S cells (the staining of intracellular Kb 
molecules is described in the next section). The IFNy- 
induced increase in K b molecules in RMA cells was accom- 
panied by a much less pronounced (1.3-fold) increase in 
OVA-FL binding. RMA/S cells demonstrate a similar small 
increase in the amount of OVA-FL binding surface mole- 
cules as RMA cells, despite a large increase in intracellular 
K b molecules. These findings demonstrate that the amount 
of cell surface peptide-receptive molecules derived from 
either the TAP-independent or TAP-dependent pool is not 
simply proportional to the rate of class I biosynthesis. 
Detection of Intracellular Class I Molecules 
in RMA and RMA/S Cells 
To quantitate intracellular class I molecules able to bind 
to OVA-FL or anti-Kb-FL, cells were fixed with 1% para- 
formaldehyde and permeabilized by inclusion of saponin 
during incubations and washes. We frequently observed 
a decrease in signal in anti-K b binding to fixed and perme- 
abilized RMA cells relative to live cells (in Figure 2A com- 
pare surface with internal staining of IFNy-treated RMA 
cells). Many of the lost K b molecules must derive from the 
plasma membrane, since RMA/S cells demonstrated a
very large increase in K b staining following permeabiliza- 
tion, owing to the detection of intracellular Kb molecules. 
It has been reported that fixation of cells with 1% parafor- 
maldehyde does not prevent peptide association with pep- 
tide-receptive class I molecules (Rock et al., 1992). As 
seen in Figure 2A, fixation and permeabilization resulted 
in a large increase of OVA-FL binding to both RMA and 
RMA/S. Three findings demonstrate the specificity of bind- 
ing. First, cells treated with IFN~, demonstrated enhanced 
binding of OVA-FL. Second, in other experiments, binding 
of OVA-FL to P815 cells was less than 10% of binding to 
RMA or RMA/S cells (data not shown). Third, and most 
importantly, Kb-binding, but not K"-binding, unlabeled pep- 
tides competed for binding to fixed and permeabilized 
RMA or RMA/S cells (data not shown). OVA-FL bound at 
4- to 5-fold higher levels to fixed and perrneabilized cells 
than to live cells. Since some class I molecules were un- 
doubtedly lost or denatured by fixation and permeabiliza- 
tion, this represents a minimal estimate of the ratio of intra- 
cellular to extracellular peptide-receptive K b molecules. It 
is also clear that RMA/S cells had more peptide-receptive 
intracellular class I molecules than RMA cells. This finding 
is consistent with the results of pulse-chase radiolabeling 
experiments, which indicated that newly synthesized class 
I molecules are retained in the ER of RMA/S cells for 
5-10 times longer than RMA cells (Townsend et al., 1989; 
Degen et al., 1992). 
Localization of Intracellular Class I Molecules 
Our findings demonstrated that both RMA and RMA/S 
cells possess a significant pool of intracellular peptide- 
receptive K b molecules. The intracellular location of class 
I molecules was examined by laser scanning confocal 
microscopy. We first examined the distribution of D b mole- 
cules in cells that were attached to coverslips prior to fixa- 
tion and permeabilization (an identical pattern was ob- 
served using MAbs specific for K ~, but the greater intensity 
of staining with D b enabled the acquisition of more struc- 
tural information). D b molecules were localized using the 
B22.249 MAb, which requires proper folding of the peptide 
binding domain (Lemke et al., 1979; Allen et al., 1984). 
As seen in the large panel in the lower left corner of Figure 
3 (lower magnification to demonstrate the uniformity of 
staining among cells), and the insert (higher magnification 
to illustrate fine structural details), class I molecules were 
prominent in the plasma membrane of RMA cells (arrow- 
heads), which formed a circular sheet around the nucleus. 
This intense staining made it difficult to detect D b in the 
cytoplasmic portions of the ER, but D b was clearly detected 
in the nucleaP membrane (arrows), which is physically con- 
tiguous with the ER and represents one of its domains. 
D b was also clearly detected in a ring-like structure that 
was revealed as the Golgi complex by double staining with 
a rabbit antiserum specific for a resident protein of the 
Golgi complex. As expected, D b molecules were not de- 
tected on the plasma membrane of RMA/S cells (Figure 
3, top left panel). This allowed the clear visualization of 
D b in the cytoplasmic portions of the ER in addition to 
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Anti-D b Anti-Golgi Complex Figure 3. Intracellular Localization of Class I Molecules 
The intracellular location f D ~ molecules and 
MG-160, a resident protein of medial Golgi 
complex, were determined in fixed and perme- 
abilized cells attached to coverslips by confo- 
cal microscopy. The left and right panels of 
each row show the same field of cells optically 
gated to show uniquely fluorescence of the 
anti-D b MAb B22.249 and the anti-MG160 anti- 
serum, respectively. Inserts demonstrate im- 
ages collected with a reduced scanning field 
to increase magnification. 
the nuclear membrane (arrows). D b molecules were also 
detected in the Golgi complex of RMA/S cells in amounts 
similar to, or greater than, those detected in RMA cells. 
This cannot be attributed to low temperature-induced re- 
distribution of D b from the ER during the fixation proce- 
dures, since cells incubated continuously at 37°C were 
fixed at this temperature by addition of prewarmed para- 
formaldehyde. 
We next examined the binding of OVA-FL and anti-KbFL 
to fixed and permeabilized cells in suspension (Figure 4). 
Consistent with the flow cytometry data, RMA/S cells were 
stained more intensely than RMA cells, which, in turn, 
were clearly stained more intensely than P815 cells, and 
much greater levels of binding of OVA-FL were observed 
to internal structures than to the plasma membrane. In 
both cells, OVA-FL most prominently stained the Golgi 
complex (arrows), with less intense staining of the ER (ar- 
rowheads). The identity of the intensely staining juxta- 
nuclear structure as the Golgi complex (arrows) in RMA/S 
cells was confirmed by the colocalization with a Kb-specific 
MAb. These findings demonstrate that in addition to their 
expected location in the ER, peptide-receptive class I mol- 
ecules are present in substantial quantities in the Golgi 
complex of both RMA and RMA/S cells. Although the stain- 
ing of the Golgi complex is more intense than that of the 
ER, it is important o note the widely dispersed nature 
of the ER compared with the highly concentrated Golgi 
complex lends itself to underestimating the amount of 
class I molecules in the ER relative to the Golgi complex. 
Quantitation of class I molecules in the two compartments 
is further complicated by the possibility that fixation and 
permeabilization have different effects on class I molecules 
in various subcompartments. Thus, the most useful infor- 
mation from intracellular staining is derived from compari- 
sons of the same organelles in RMA and RMA/S cells. 
Quantitation of Class I Traffic Through the Golgi 
Complex of RMA and RMA/S Cells 
Immunofluorescence localization of intracellular Kb mole- 
cules suggested that similar amounts of class I transit the 
Golgi complexes of RMA and RMA/S cells. Probably the 
best-characterized marker of the trans-Golgi complex is 
galactosyl transferase, which catalyzes the addition of ga- 
lactose from UDP-galactose to terminal N-acetyglucos- 
amine residues. To measure class I transit through the 
trans-Golgi complex, RMA and RMA/S cells were pulse 
radiolabeled with [1-3H]galactose. Class I molecules pres- 
ent in detergent lysates were collected sequentially using 
Figure 4. Intracellular Localization of Peptide- 
Receptive Class I Molecules 
The intracellular localization ofOVA-FL in fixed 
and permeabilized cells was determined by 
confocal microscopy. The large panels were 
acquired with exactly the same instrument set- 
tings to demonstrate th specificity of binding. 
In the small panels, double staining wasper- 
formed using OVA-FL (left) and the Y3 MAb, 
which was visualized by addition of Texas red- 
conjugated onkey anti-mouse IgG. 
OVA-FL K b 
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Figure 5. Characterization of [1-3H]Galactose-Labeled Class I Mole- 
cules 
A. Imrnunopurification of [1-3H]galactose-labeled molecules. Cells 
were labeled for 15 min at 2O°C and chased for 10 min at 37°C and 
extracted in 200 pl. The amount of TCA-insoluble counts present in 
a 5 pl aliquot determined by scintillation counting was 37,264 dpm for 
RMA cells and 36,945 dpm for RMA/S cells. The remainder of the 
extract was sequentially collected using protein A-agarose beads pre- 
loaded with 28-14-8S MAb, followed by beads loaded with anti-exon 
8 antiserum, and then with protein G-agarose beads loaded with the 
rat MAb R17 217.1.3, specific for the mouse transferrin receptor (TfR). 
Irnmunopurified material was analyzed by SDS-PAGE using 12.5% 
separating gels and fluorography. Molecular mass markers are shown 
for each gel by arrowheads (top to bottom): 200 kDa, 97 kDa, 69 kDa, 46 
kDa, 30 kDa, 21 kDa, 14 kDa. The ratio (RMA/S:RMA) of radioactivity 
migrating in the major bands was determined by ~ensitometry: TfR = 
1.22; D b = 1.27; K b = .96. 
B. Glycosidase treatment of [1-3H]galactose-labeled K bmolecules re- 
active with anti-exon 8 antiserum. K b molecules were collected from 
detergent extracts of cells pulse radiolabeled for 15 min at 18°C and 
chased for 0, 10, or 20 rain at 37°C. Cells were grown overnight in 
media supplemented with 20 U/ml mouse IFNy to increase class I 
transcription (similar results were obtained using cells not exposed to 
IFNy). In lanes denoted (C), cells were treated with neuraminidase at 
O°C after the chase period. Purified K b molecules were treated with 
endo H (h) or neuraminidase (E) prior to electrophoresis. 
C. Conformation of [1-3H]galactose-labeled K b molecules. K b mole- 
cules were collected sequentially from detergent extracts from cells 
labeled for 15 min at 37°C. As indicated, extraction buffer contained 
a mixture of three Kb-binding peptides (SIINFEKL, FAPGNYPAL, RGY- 
VYQKL), each present at 2 i~g/ml, or human .~2m at 5 pg/ml with the 
peptide mixture. Extracts were incubated twice with protein A-agarose 
beads coated with each antibody; this resulted in the removal of at 
least 94% of the reactive species (K b recovered on the first incubation 
is shown on the left of each pair). The percentage of K b reactive with the 
conformation-specific MAb Y3 (176) of the total amount K b recovered is 
indicated. 
D. Degradation of K b molecules reactive with anti-exon 8 antiserum. 
K b molecules reactive with anti-exon 8 antiserum were collected from 
detergent extracts derived from cells pulse radiolabeled for 30 min at 
37°C and chased for the indicated times at 37°C or 26°C. 
protein A -agarose  beads loaded with a MAb (28-14- 
8S) specific for an ~3 domain determinant present on na- 
tive and partially folded D ° molecules (Ozato and Sachs, 
1981, Townsend et al., 1989), prior to beads loaded with 
a rabbit ant iserum raised to a synthet ic  pept ide corre- 
sponding to COOH terminus of K b encoded by exon 8 of 
the K b gene. Exon 8-specif ic sera have been shown to 
bind both folded and unfolded K b molecules (Smith and 
Barber, 1990; Joyce et al., 1994). Nearly identical amounts 
of K b and D b were recovered from RMA and RMA/S cells 
(Figure 5A). This accurately reflects the concentration of 
class I molecules in the trans-Golgi complex available for 
galactosylation of the two cell lines (and not enhanced 
incorporation of [1-3H]galactose by RMA/S cells), since 
the two cell lines incorporated nearly identical amounts 
of [1-3H]galactose into either the transferrin receptor or 
the pool of TCA precipitated etergent soluble macromole- 
cules. [1-3H]galactose can potentially be converted into 
3H-labeled am ino acids, but conversion is unlikely to occur 
under the short pulse labeling conditions utilized, and was 
not detected by incorporation into either ~2m (Figure 5A), 
or a nonglycosylated influenza virus protein (nucleopro- 
tein) abundantly expressed following infection of cells with 
influenza virus (data not shown). [1-3H]gatactose can also 
potentially be converted to [1 _3 H]-glucose. Glucose is pres- 
ent on the high mannose oligosaccharide transferred to 
the nascent polypeptide chain in the ER, and can also be 
added post-translationally to N-linked ol igosaccharides on 
proteins retained in the ER (Kornfeld and Kornfeld, 1985; 
Trombetta et al., 1989). Glycosidase treatments were used 
to help discriminate between these possibilities. Cells 
were pulse labeled at 18°C and chased for 10 or 30 min at 
37°C, and K ~ molecules collected from detergent extracts 
using agarose beads coated with anti-exon 8 antiserum 
were analyzed by SDS-PAGE.  As seen in Figure 6B, more 
labeled K b was recovered in the chase than immediately 
following pulse labeling. This lag, which was frequently 
observed in experiments in which labeling was performed 
at temperatures of 20 ° C or less, likely reflects delays either 
in the conversion of [1-3H]galactose to U DP-[1-3H]galactose 
(which donates galactose to oligosaccharides), or the 
transport of UDP-[1-3H]galactose from its sites of synthe- 
sis in the cytosol to the Golgi complex. Purified K b mole- 
cules were treated with endo-13-N-acetylglucosaminidase 
H (endo H), which removes glucose containing high man- 
nose oligosaccharides, but not mature nonhybrid oligo- 
saccharides containing galactose residues (Maley et al., 
1989). While this treatment (denoted as h in the figure) 
had no effect on K b recovered from RMA cells, radiolabel 
was completely removed from a faster migrating form of 
K b variably produced by RMA/S cells (detected in approxi- 
mately half the experiments). This species could represent 
K b molecules retained in the ER that have been posttrans- 
lationally transiently glucosylated through the action of 
UDP-glucose glycoprotein transferase (Sousa et al., 1992). 
It is also possible, however, that these molecules possess 
hybrid biantennary oligosaccharides containing [1-3H]galac- 
tose, since such ol igosaccharides hould also be cleaved 
by endo H. The difference in mobil ity in endo H-sensit ive 
and -resistant K b is attr ibutable to the rapid sialylation 
of galactosylated oligosaccharides, as demonstrated by 
treating purified K b with neuraminidase to remove terminal 
sialic acids from N-linked ol igosaccharides ("E"). To deter- 
mine whether sialylated [1-3H]galactose-labeled mole- 
cules were transported to the cell surface or were retained 
intracellularly, cells were treated with neuraminidase at 
0°C prior to detergent extraction (C) (note that labeling 
Localization of Peptide-Receptive Class I Molecules 
143 
was performed at 18°C to accumulate Kb in the trans-Golgi 
complex [Matlin and Simons, 1983], and thereby synchro- 
nize transport to the cell surface upon temperature shift 
up). The mobility of pulse-labeled K b was unaffected by 
neuraminidase treatment, confirming that the enzyme was 
not internalized by cells or active in detergent extracts. 
After 10 min chase, approximately 25% of the K b mole- 
cules from RMA cells, and at least as high a percentage 
from RMA/S cells, demonstrated an increase in mobility 
resulting from exposure of the cells to neuraminidase. 
After an additional 10 min, all of the K b molecules derived 
from neuraminidase-treated RMA and RMA/S cells dem- 
onstrated this mobility shift. (Note that the mobility shift 
is not as complete on a subset of molecules as observed 
following treatment of detergent extracts or purified mole- 
cules. Since longer treatment of the cells did not increase 
the magnitude of the mobility shift, the partial effect indi- 
cates that only some of the terminal sialic acid residues 
on a portion of cell surface K b molecules are accessible 
to the enzyme.) Similar findings were made regarding 
transport of D b molecules collected from the same extracts 
using MAb 28-14-8S-coated beads (data not shown). 
We next examined the conformation of [1-3H]galactose- 
labeled K b molecules by sequential collection using aga- 
rose beads coated with the Y3 MAb (Hammerling et al., 
1982), which is specific for native K b molecules containing 
either mouse or human 132m, followed by collection with 
anti-exon 8 antiserum-coated beads (Figure 5C). This re- 
vealed that 74% of K b molecules in RMA extracts, but only 
1% of K b molecules in RMA/S extracts were present in 
MAb reactive (i.e., native) conformation. Virtually all of the 
unfolded molecules from either cell could be converted to 
the MAb reactive conformation by inclusion of Kb-binding 
peptides and human 132m in the extraction buffer, with an 
intermediate amount being converted by inclusion of pep- 
tides alone. Thus, none of the detergent extractable class 
I molecules coursing through the Golgi complex of either 
cell type are irreversibly unfolded. 
The turnover of [1-3H]galactose-labeled K b molecules 
was determined by incubating cells for up to 3 hr at 37°C 
after pulse labeling (Figure 5D). Most detergent soluble 
[1-3H]galactose-labeled anti-exon 8 reactive K b molecules 
were lost by RMA/S cells over the chase period. By con- 
trast, [1-3H]galactose-labeled K bmolecules were stable in 
RMA cells over the same period. Turnover in RMA/S cells 
was inhibited by 26°C incubation. Nearly identical findings 
were made regarding the fate of D b molecules reactive 
with the 28-14-8S MAb (data not shown). These findings 
are consistent with the enhancing effect of 26°C incuba- 
tion on surface expression and recovery of [35S]methio- 
nine-labeled class I molecules (Ljunggren et al., 1990). 
Since all of the sialylated [1-3H]galactose-labeled class I 
molecules in RMA/S cells reach the cell surface, much of 
the degradation of class I molecules in RMA/S cells must 
occur after the molecules reach the cell surface. This con- 
clusion is supported by the observations of Neefjes et al. 
(1992) that exon 8-reactive radioiodinated RMA/S cell sur- 
face K b molecules are degraded at a similar rate as our 
[1-3H]galactose-labeled molecules. 
Discussion 
Nature of Peptide Receptive Cell Surface 
K b Molecules 
There are four general mechanisms (Elliot, 1991) by which 
OVA-FL could bind to K b molecules at the surface of live 
cells. First, OVA-FL binds weakly to free ~ chains (i.e., 
lacking ~m), and is secured by binding of free 132m. Sec- 
ond, OVA-FL binds to free ~ chains. Third, ~z132m hetero- 
dimers remain intact as OVA-FL displaces endogenous 
high affinity peptides loaded in the ER. OVA-FL binds to 
~2m heterodimers that are either truly empty, or have a 
low affinity ligand in their groove. 
The dependence of OVA-FL binding on culturing cells in 
media containing 1~2m eliminates the first two possibilities, 
and renders the third rather unlikely. Three additional find- 
ings indicate that peptide displacement could only account 
for a small portion of OVA-FL binding. First, OVA-FL is 
not displaced by its unlabeled analog. Second, transient 
exposure of cells to high affinity Kb-binding peptides blocks 
OVA-FL binding. Third, peptide-receptive molecules are 
extremely unstable when 132m is removed from media. 
Thus, we believe that the vast majority of OVA-FL binding 
to cells is due to binding of (~l~2m heterodimers formed 
by the association of exogenous 132m with (~ chains devoid 
of both endogenous 132m and high affinity peptides. This 
conclusion is in concordance with previous studies dem- 
onstrating an absolute requirement for exogenous 132m for 
the presentation of synthetic peptides to Kb-restricted TcDs÷ 
(Vitiello et al., 1990, Rock et al., 1990). 
Intracellular Trafficking of TAP-Independent 
K b Molecules 
Baas et al. (1992) previously reported the presence of H LA 
B5 molecules throughout the stacks of the Golgi and pro- 
posed that peptide loading might occur throughout he 
Golgi complex. Two lines of more recent evidence sug- 
gest, however, that any peptide loading accomplished in 
the Golgi complex would only occur in the cis region. First, 
class I molecules are now thought to be tethered to TAP 
during peptide loading (Ortmann et al., 1994; Suh et al., 
1994), and TAP has been localized by immunoelectron 
microscopy to the ER and cis-Golgi complex (Kleijmeer 
et al., 1992). Second, class I molecules demonstrating 
retarded transport in TAP-deficient cells possess N-linked 
oligosaccharides sensitive to endo H digestion (Hammond 
et al., 1994; Jackson et al., 1994; Ortmann et al., 1994; 
Suh et al., 1994), indicating that they have not encountered 
Golgi rnannosidase II, which is normally active in the me- 
dial or trans regions of the Golgi complex (Kornfeld and 
Kornfeld, 1985). Analysis of N-linked oligosaccharides as- 
sociated with D b molecules retained in RMA/S cells (which 
maintain TAP-specific binding of class I molecules even 
though they express only one of the TAP subunits; Suh 
et al., 1994) indicates that these oligosaccharides are in 
the Mans_gGIcNAc2 form (Hayes et al., submitted), and 
therefore have also not encountered Golgi complex 
~-mannosidase I, which is active in the medial Golgi com- 
plex, and perhaps also the cis-Golgi network (the proximal 
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portion of the Golgi complex that most directly interfaces 
with proteins exported from the ER; Mellman and Simons, 
1992). Moreover, peptides have been shown to associate 
with chimeric K a whose cytosolic domain was replaced 
with an ER-retention sequence (Lapham et al., 1993). 
Such K d molecules persist in an endo H-sensitive state, 
and are excluded from the Golgi complex as identified by 
the same antiserum used to locate the Golgi complex in 
Figure 4. These findings indicate that the class I molecules 
detected by Baas et al. (1992) in the medial and trans-Golgi 
complex of TAP-deficient cells, as well as the class I mole- 
cules we detect in the RMA/S Golgi complex by immuno- 
fluorescence, largely represent class I molecules, en route 
to the plasma membrane, that were released from the 
proximal regions of secretory pathway without high affinity 
peptides. 
The time-dependent disappearance of immunoreactive 
class I molecules in detergent lysates of RMA/S cells la- 
beled with [3~S]methionine pulse-chase experiments has 
generally been interpreted to indicate that a high percent- 
age of molecules are degraded in the ER. Using a transla- 
tionally incorporated isotope, however, it is difficult o dis- 
tinguish ER degradation of a substrate from delayed ER 
export to a more distal compartment where the substrate 
is rapidly degraded. To surmount his difficulty, we labeled 
class I molecules with [1-3H]galactose, which provides a 
direct measure of class I transport hrough the trans-Golgi 
complex. Similar levels of [1-3H]galactose incorporation 
into class I molecules in RMA and RMA/S cells indicates 
that class I molecules are delivered at similar rates to the 
trans-Golgi complexes of the two cells. Neuraminidase 
treatment of living cells further demonstrates that class I 
molecules are transported at similar rates from the trans- 
Golgi complexes to the surface of the two cells. The poor 
reactivity of RMA/S K b [1-3H]galactose-labeled molecules 
with native specific MAb in the absence of added peptides 
indicates that the vast majority of these molecules lack a 
high affinity peptide. Thus, the trans-Golgi complex does 
not possess an ER-type quality control mechanism that 
retains class 1 molecules based on the absence of tightly 
bound peptides. It is very possible, however, that the con- 
centration of 132m is higher in the Golgi complex than in 
the ER. Since l~2m at high concentrations in the absence 
of peptides has been shown to favor the native conforma- 
tion of class I molecules (Townsend et al., 1990), this could 
substitute for the lack of high affinity peptides. We favor the 
idea that high concentrations of 132m in the Golgi complex 
account for the high concentration of peptide-receptive 
molecules detected in fixed and permeabilized cells, and 
for the intense staining of the Golgi complex by MAbs 
specific for native class I conformation. 
We show that [1-3H]galactose-labeled K bmolecules are 
degraded after they have been delivered to the plasma 
membrane. Additional experiments indicate that degrada- 
tion is decreased by approximately 50% by incubating 
cells with agents that interfere with endosomal/lysosomal 
acidification (NH4CI or methylamine; unpublished data), 
suggesting that at least a portion of K b molecules are de- 
graded in an endosomal/lysososmal compartment. This 
would be consistent with reports that class I molecules 
are internalized into an endosomal compartment (Capps 
et al., 1989; Dasgupta et al., 1988; Motal et al., 1993; Tse 
and Pernis, 1984). 
Taken together, our findings show that class I pools in 
the Golgi complexes of RMA and RMA/S cells are of a 
similar size and dynamic nature. This indicates that while 
class I molecules dwell for greater periods in the early 
secretory compartment of RMA/S cells, the rate of export 
is similar to that occurring in RMA cells. The export of 
class I molecules from the ER of RMA/S cells could reflect 
their inappropriate release by quality control mechanisms. 
Alternatively, class I molecules might inappropriately sig- 
nal for their release from the ER by adopting a folded 
conformation randomly or by binding a low affinity ligand 
(be it peptide or loop or terminus from a protein). 
Source of Peptide-Receptive Surface K b Molecules 
Possibly the most interesting observation we have made 
is that RMA cells bind up to 5-fold more OVA-FL than 
RMA/S cells. In additional experiments we find that follow- 
ing incubation at 37°C for between 3 and 24 hr with either 
SIINFEKL or the Db-binding peptide ASNENMETM, much 
greater numbers of additional MAb-reactive K b and D b mol- 
ecules, respectively, are recruited to the surface of RMA 
cells than RMA/S cells (unpublished ata). These findings 
are in apparent conflict with a previous report that 2- to 
3-fold greater amounts of a radioiodinated 12 residue K b- 
binding peptide are recovered from RMNS cells than from 
RMA cells using beads coated with anti-H2 b antiserum to 
collect class I-bound peptides (Schumacher et al., 1990). 
In this study, cells were incubated for 2 hr in brefeldin A 
at 26°C or 37°C, possibly in the presence of low levels 
of ~2m, prior to being exposed to peptides. This may have 
had a greater effect on peptide-receptive K b molecules 
present on RMA than on RMA/S cells, particularly since, 
in contrast with our findings, barely detectable levels of 
peptides were bound to cells at 4°C Alternatively, it is 
conceivable that the amount of antibodies reactive with 
native K b used to recover peptide class I complexes was 
limiting, resulting in only partial recovery of peptide con- 
taining molecules from RMA cells, which contain more 
than 10-fold greater amounts of native K b molecules than 
RMNS cells. 
The experiments hown in Figures 5B and 5C indicate 
that virtually all of the K b molecules reaching the plasma 
membrane of RMNS cells are capable of binding pep- 
tides, and that this pool is similar in size to the total pool 
of K b molecules reaching the surface of RMA cells. Since 
a sizable fraction of the latter material already has a high 
affinity peptide and would not be available for binding 
OVA-FL, it is paradoxical that RMA cells bind considerably 
more OVA-FL than RMA/S cells. The likely solution to this 
puzzle is that the class I molecules in RMA/S cells rapidly 
denature irreversibly upon reaching the cell surface. Thus, 
TAP expression, rather than decreasing the amount of pep- 
tide-receptive molecules, actually has the opposite effect. 
TAP could enhance the expression of peptide-receptive 
molecules by acting alone or in concert with other chaper- 
ones (such as calnexin) to enhance class I folding to en- 
able the molecules to maintain native structure in the ab- 
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sence  of  l igands. It seems more  likely, however ,  that the 
load ing  of low aff inity TAP- t ranspor ted  pept ides  onto  class 
I mo lecu les  induces  conformat iona l  a l terat ions  in the 
chain  that persist  after pept ide d issoc iat ion.  Such pept ides 
cou ld  be of low intrinsic aff inity (or be of  h igh affinity, but 
improper ly  loaded),  and might d issoc iate in the sl ightly 
acid mil ieu of  the Golgi  complex .  Our  f ind ings indicate that 
such molecu les  soon lose 1~2m upon their arr ival  at the cell 
sur face  and regain pept ide recept iv i ty only upon binding of  
exogenous  1~2m. The proposed  imprint ing of  c lass I mole- 
cu les  by pept ides  has its p recedent  in the operat ion of  
mo lecu lar  chaperones ,  which,  by promot ing  the proper  
fo ld ing pathway,  can confer  a last ing ef fect  on proteins 
after  t rans ient  associat ion.  Whi le  it is not diff icult to envi- 
s ion pept ides  per forming a s imi lar  role, this remains  to be 
estab l i shed exper imenta l ly .  
Experimental Procedures 
Materials 
Reagents were purchased from the following sources: Fmoc-amino 
acids, piperidine, disopropylethamine and 0.5 M HOBt/DMF from Ap- 
plied Biosystems, Incorporated, California; Fmoc-Leu-Wang resin 
from Novabiochem, California; Diisoprobylcarbodiimide, ethanedithiol 
(EDT), thianisole, and anisole from Fluka, New York; trifluroacetic acid 
(TFA) from Schweizerhall, H. J.; 5- and 6-carboxyfluoroescein-N- 
hydrorzysuccinimide ester (mixture of isomers) from Research Organ- 
ics, Cleveland, Ohio. Dimethylformamide (DMF), methylene chloride, 
acetonitrile, and methyl-butyl ether from Burdick and Jackson divi- 
sion of Baxter Scientific, Illinois. [1-3H]galactose (540 Gbq/mM) and 
EN3HANCE were from Dupont, Boston, Massachusetts. Clostridium 
perfringens neuraminidase was from Sigma, St. Louis, Missouri. Vibrio 
cholerae neuraminidase and endo H were from Boehringer Mannheim, 
Indianapolis, Indiana. Kb-specific MAb conjugated to fluorescein was 
from PharMingen, San Diego, California. MAbs 28-14-8S (HB27), 
BBM. 1 (H B28), Y3 (H B176), R17 217.1.3 (TIB 219) we re from American 
Type Culture Collection, Rockville, Maryland. Fluorescein-conjugated 
rabbit anti-mouse immunoglobulin G (IgG) was from Dako, Carpinteria, 
California. Protein A-agarose was from Repligen, Cambridge, Massa- 
chusetts. 
Peptide Synthesis 
All peptides were synthesized by standard solid-phase methodology 
using an AB1430A peptide synthesizer. Fmoc strategy, utilizing double 
coupling of the HOBt-activated ester in DMFwas employed. To synthe- 
size peptides with fluorescein-conjugated Lys, protected peptide resin 
was washed with methylene chloride and air-dried. The crude peptide 
with a Fmoc-protecting roup at the NH2-terminus was released from 
the resin by treating for 2 hr with TFA containing scavengers (TFA: 
thianisole:anisole:EDT at90:5:2:3, v/v/v/v). Following vacuum concen- 
tration, the crude peptide was mixed with methyl-butyl ether, filtered, 
and conjugated to fluorescein by reacting the peptide at concentration 
of 0.1 mM DMF with 0.25 mM 5- (and 6-) carboxyfluorescein-N-hydro- 
succinimide ester and 0.5 mM disopropylethamine for 48 hr. The or- 
ange precipitate obtained following dilution of the reaction mixture 
with water was concentrated by filtration, dissolved in 15 ml dilute 
aqueous ammonia (pH 8.5), and mixed with 5 ml piperidine to remove 
the Fmoc-protecting roup at the NH2 terminus. After 5 hr incubation, 
the suspension was diluted with an equal volume of water, filtered, 
and the filtrate acidified at 0°C with acetic acid to pH 6-6.5. The filtrate 
was loaded on a reverse phase preparative high pressure liquid chro- 
matography (HPLC) column (Waters Delta Pak C18-300,~,. 19 mm x 
30 cm, 15 p. particle size), and chromatographed using a gradient 
consisting of 25%-45% solvent B over 40 rain (flow 12 ml/min, solvent 
A 0.1% TFA, water, solvent B, 0.1% TFA, 80% acetonitrile/water) 
with monitoring at 215 nm. Individual fractions were collected and 
combined based on analytical HPLC performed in parallel. Pooled 
fractions were lyophilized and stored at -20°C. The fluorescent pep- 
tide was assayed for purity by analytical HPLC using a Rainin Dynamax 
300 ,A, 5 p., 4.6 x 250 mm column and a gradient of 0%-70% B over 
40 rain. Amino acid analysis was performed on a Beckman model 
6300 analyzer. Laser desorption mass spectroscopy was performed 
on a Vestec research MALDI-TOF mass spectrometer equipped with 
a 337 nm nitrogen laser and a 1.2 m flight tube. The acceleration 
potential was 20 kV and the matrix was a-cyano-4-hydrocinnamic a id. 
Internal calibration was performed using matrix peaks. Peptide purity 
was determined to be greater than 99% by these criteria. The unla- 
beled peptides ovalbumin 256-276 (SIINFEKL), vesicular stomatitis 
virus nucleocapsid protein (N) 52-59 (RGYVYQGL), Sendal virus nu- 
cleopretein (NP) 324-332 (FAPGNYPAL), influenza virus NP 147- 
155 (TYQRTRALV) and NP 366-374 (ASNENMETM), were synthe- 
sized and analyzed as described above. The purified, lyophilized prod- 
ucts were reconstituted in DMSO at 1 mg/ml and stored as stocks 
at -20°C. 
Cell Lines 
RMA, RMNS (Ljunggren and K~rre, 1985), and P815 cells were main- 
tained as suspension cultures in RPMI 1640 media with 7.5% (v/v) 
FBS. RMA and RMNS cells were provided by Dr. K. K~rre (Karolinska 
Institute, Stockholm, Sweden). 
Flow Cytometry 
Cells (1 x 106/well) were incubated for 10 rain on ice with various 
concentrations of OVA-FL in 150 I11 PBS supplemented with 0.1% 
(w/v) azide (PBS-azide). All manipulations were performed using 96- 
well round-bottomed plates. For peptide-blocking experiments, cells 
were preincubated with the indicated unlabeled peptide for 10 rain on 
ice, washed three times in PBS-azide, and incubated with OVA-FL. 
Following OVA-FL incubation, cells were washed three times with 
PBS-azide and analyzed using a cytofluorograph. For direct antibody 
staining, 1 x 108 cells were incubated for 30 min on ice with 1 p.g/ml 
of the Kb-specific MAb AF6-88.5.3 (Loken and Stall, 1982) directly 
conjugated to fluorescein. For indirect antibody staining, cells were 
incubated for 45 rain at 0°C, washed, and incubated for 45 min at 
0°C with fluorescein-conjugated rabbit anti-mouse IgG. 
Intracellular Staining 
For staining with OVA-FL, cells were washed three times with cold 
PBS, fixed by 10 rain incubation at room temperature with 1.0% para- 
formaldehyde, and washed three times with PBS supplemented with 
200 mM giycine to quench free aldehyde groups. Cells were then 
incubated for 20 min on ice with PBS supplemented with saponin 
(0.1% w/v) and 5 p.g/ml OVA-FL, washed three times in PBS, 0.1% 
saponin, suspended in PBS-MOWiOL glycerol containing 5% diaza- 
bicycle-octane (PMD), or FluorSave (Calbiochem, La Jolla, California), 
coverslipped, and examined using a BioRad MRC 600 laser scanning 
confocal system attached to a Zeiss Axioplan microscope. For colocali- 
zation of class I molecules with a Golgi complex-specific antiserum, 
cells were attached to #01 coverslips that had been derivatized with 
concanavalin A as described (Lippincott-Schwartz et al., 1989), and 
fixed for 20 min at 37°C with PBS containing 0.5% paraformaldehyde 
(w/v). After washing, coverslips were incubated with rabbit antisera 
specific for a resident protein of medial Gelgi complex termed MG160 
(Gonatas et al., 1989), washed, and incubated with fluorescein-con- 
jugated goat anti-rabbit IgG. After washing, coverslips were incubated 
with rabbit serum to block unbound sites in anti-rabbit IgG, and then 
with hybridoma culture fluid containing the Db-specific MAb B22.247 
(Townsend et al., 1969). Coverslips were then washed, incubated with 
rhodamine-conjugated anti-mouse IgG, and washed a final time before 
mounting in PMD. All images were acquired with a Zeiss 63 x N.A, 1,4 
planapo objective using the photon counting mode. Control coverslips 
established that antibody binding was specific for the intended antigen, 
and that fluorescence in green and red channels did not overlap. Im- 
ages transferred to a Macintosh Quadra 700 were collaged and grey 
scale-adjusted using the Adobe Photoshop program. Hard copies of 
the images were produced using a Kodak XL7700 digital printer. 
Biochemical Procedures 
For labeling with [1-3H]galactose, 108 cells were 1 ml glucose-free 
RPMI 1640 supplemented with 20 mM HEPES (pH 7.2), 0.1% BSA, 
and 2 mCi [1-3H]galactose. Cells were then washed with PBS con- 
taining 5 mM galactose, resuspended in RPM11640 containing 7.5% 
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FBS and 20 mM HEPES (pH 7.2), incubated on ice (for pulsing) or at 
the indicated temperature and time. In the experiment shown in Figure 
5B, one-third of the cells collected at each timepoint were incubated 
for 60 rain at 4°C in 100 ~.1 of PBS supplemented with 1 mM CaCI2 
and 0.5 U clostridium perfringens neuraminidase, and then washed 
three times with PBS containing 20% FBS. [1-SH]galactose-labeled 
material was extracted from cells by suspending cells in extraction 
buffer (140 mM NaCI, 1 mM EDTA, 10 mM Tris-HCI [pH 7.2], 2% [v/v] 
Triton X-100, 10 p.M leupeptin, 1 ~M pepstatin), supplemented with 
100 i~g/ml fetuin to neutralize any remaining neuraminidase when ap- 
propriate, and centrifuged at 15,000 x g for 10 min to removed insolu- 
ble material. K b molecules were collected on protein A-sepharose 
preloaded with an exon 8-specific rabbit antiserum (provided by B. Bar- 
ber, University of Toronto, Toronto, Ontario, Canada, or S. Joyce, Penn- 
sylvania State Medical College, Hershey, Pennsylvania), or MAbs as 
indicated, and extensively washed. Where appropriate, samples were 
digested overnight at 37°C with endo H in 50 mM sodium acetate, 2.5 
mM EDTA, 1.6 mM Tris (pH 6.8), 0.3% SDS, 0.6% 2-mercaptoethanol, 
1 mM PMSF, or with 10 mU vibrio cholerae neuraminidase in 50 mM 
sodium acetate (pH 6.0), 10 mM CaCI2. Samples were then analyzed 
by SDS-PAGE with 10 cm (or for Figure 5D, 5 cm) 12.5% acrylamide 
gels (37.5:1, acrylamide:bisacrylamide), using the conditions of Laem- 
mli (1970). Gels were impregnated with EN3HANCE, dried under vac- 
uum, and exposed for 3 months at -80°C to preflashed Kodak XAR-5 
film. The emulsion on the nonexposed side of the film was removed 
by chlorox treatment to increase the signal to noise ratio. Fluorographs 
were digitally scanned into a Gateway PC using a Hewlett-Packard 
flatbed scanner operating in transparency mode, and images were 
digitally enhanced and arranged using Adobe Photoshop software. 
The relative intensities of pixels within experiments were not altered. 
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